Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Fuji
Cantor Fitzgerald
US Department of Justice
McKinsey
Medtronic
Chinese Patent Office
Queensland Health
Baxter
Johnson and Johnson

Generated: January 16, 2018

DrugPatentWatch Database Preview

TRETINOIN Drug Profile

« Back to Dashboard

When do Tretinoin patents expire, and when can generic versions of Tretinoin launch?

Tretinoin is a drug marketed by Anchen Pharms, Barr Labs Inc, Glenmark Pharms Ltd, Allergan Sales Llc, Perrigo Pharma Intl, Zo Skin Health, Mylan Pharms Inc, Teva Pharms, and Wockhardt. and is included in sixteen NDAs.

The generic ingredient in TRETINOIN is tretinoin. There are twenty-four drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
Drug patent expirations by year for TRETINOIN
Pharmacology for TRETINOIN
Ingredient-typeRetinoids
Drug ClassRetinoid
Medical Subject Heading (MeSH) Categories for TRETINOIN

US Patents and Regulatory Information for TRETINOIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anchen Pharms TRETINOIN tretinoin CAPSULE;ORAL 201687-001 Oct 24, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo Pharma Intl TRETINOIN tretinoin CREAM;TOPICAL 075265-001 Dec 24, 1998 AB1 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Allergan Sales Llc TRETINOIN tretinoin CREAM;TOPICAL 090098-001 Mar 22, 2010 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Pharms Inc TRETINOIN tretinoin GEL;TOPICAL 202026-001 Jul 17, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo Pharma Intl TRETINOIN tretinoin CREAM;TOPICAL 075213-001 Dec 24, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt TRETINOIN tretinoin SOLUTION;TOPICAL 075260-001 Jan 25, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo Pharma Intl TRETINOIN tretinoin GEL;TOPICAL 075529-001 Feb 22, 2000 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr Labs Inc TRETINOIN tretinoin CAPSULE;ORAL 077684-001 Jun 22, 2007 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Pharms Ltd TRETINOIN tretinoin CAPSULE;ORAL 208279-001 Dec 23, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo Pharma Intl TRETINOIN tretinoin CREAM;TOPICAL 075264-001 Dec 24, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Covington
Johnson and Johnson
Teva
Harvard Business School
Moodys
Cipla
Argus Health
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot